✦ LIBER ✦

Interferon-alpha (IFN-a) in combination with carboplatin (C) vinblastine (V) and bleomycin (B) in metastatic malignant melanoma (M.M.)

✍ Scribed by Bafaloukos, D.; Pavlidis, N.; Skarlos, D.; Fountzilas, G.; Klouvas, G.; Giannakakis, T.; Kosmidis, P.

Book ID: 122539228
Publisher: Elsevier Science
Year: 1993
Tongue: English
Weight: 149 KB
Volume: 29
Category: Article
ISSN: 0959-8049
DOI: 10.1016/0959-8049(93)91631-T

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Recombinant interferon alfa-2a in advanc

Recombinant interferon alfa-2a in advanced malignant melanoma. a phase i-ii study in combination with dtic

✍ G. R. C. McLeod; D. B. Thomson; P. Hersey 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 French ⚖ 384 KB

There is a rising incidence of malignant melanoma world-wide and, despite major improvements in i t s early diagnosis and treatment, the 10-year death rate remains at 20-25%. Evidence that the immune system has a role in the control of melanoma growth has encouraged immunological intervention. The r

Successful treatment of metastatic melan

Successful treatment of metastatic melanoma by adoptive transfer of blood-derived polyclonal tumor-specific CD4+ and CD8+ T cells in combination with low-dose interferon-alpha

✍ Els M. E. Verdegaal; Marten Visser; Tamara H. Ramwadhdoebé; Caroline E. van der 📂 Article 📅 2011 🏛 Springer-Verlag 🌐 English ⚖ 598 KB

A phase I study of recombinant human int

A phase I study of recombinant human interleukin-2 and alpha-interferon-2a in patients with renal cell cancer, colorectal cancer, and malignant melanoma

✍ A. Mittelman; M. Huberman; C. Puccio; B. Fallon; J. Tessitore; S. Savona; R. Eyr 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 662 KB

Preclinical data suggest synergy of interleukin-2 (IL-2) combined with alphainterferon (IFN). In addition, toxicities of IL-2 may be decreased by intermittent continuous infusion. The purpose of this trial was to determine the maximum tolerated dose (MTD) of recombinant IL-2 combined with alpha-IFN

150 - Subcutaneous (SC) interleukin-2 (I

150 - Subcutaneous (SC) interleukin-2 (IL-2) plus alpha interferon (IFN-α) and 5 fluorouracil (5 FU) in out-patients (pts) with metastatic renal cell carcinoma (MRCC). Scapp II trial

✍ J.M. Tourani; A. Benhammouda; P. Guillet; C. Pfister; B. Paule; J.F. Berbah; Y. 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 262 KB

Aerosol liposomal interleukin-2 (AIL-2)

Aerosol liposomal interleukin-2 (AIL-2) combined with interferon alpha-2B/ribavirin (IFN/R)as a novel approach in chronic hepatitis C (HCV) patients who failed previous IFN/R treatment: a preliminary report: Nizar N Zein, Rosa M Ten, John B Gross Jr., Mayo Clinic, Rochester, MN; Rolland C Dickson, Mayo Clinic, Jacksonville, FL; John J Poterucha, Laurie A Czaplewski, Claudia O Zein, Mayo Clinic, Rochester, MN

📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 216 KB

Combination pegylated interferon alpha-2

Combination pegylated interferon alpha-2b and ribavirin in transplant patients with recurrent hepatitis C infection: a preliminary report: Hugo E Vargas, Marianne J Rosati, David D Douglas, M E Harrison, David C Mulligan, Adyr A Moss, Jorge Rakela, Vijay Balan, Mayo Clinic Arizona, Phoenix, AZ

📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 194 KB